VCEL Vericel Corp

NEUTRAL Impact: 2/10 144
Horizon days Filed Jun 2, 2026 Processed 3d 1h ago SEC 0001959173-26-004258
Form 144 — notice of proposed sale of securities
Latest settled — T+1d
VCEL ▲ +0.84% at T+1d
NEUTRAL call ✓ call won +0.84% · α vs SPY +1.54% · entry $34.45 → $34.74
Next anchor: T+5d in 4d
Currently $36.03 · +4.60% from $34.45 entry
Entry anchored
Jun 2, 02:39 PM ET
via Databento tick
T+1d
+0.84%
call +0.84% · α +1.54%
$34.74
settled 2d ago
T+5d
call — · α —
in 4d
T+20d
call — · α —
in 26d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Jonathan M. Hopper, an officer of Vericel Corp, filed a Form 144 on June 2, 2026, indicating intent to sell 4,375 shares of common stock with an estimated market value of $153,125. The shares were acquired via an option grant dated February 6, 2019, and the sale is planned as a cash transaction through Fidelity Brokerage Services. This is a relatively small sale relative to the company's $1.7B market cap and follows a pattern of insider selling (5 sales totaling $588K in the past 30 days), but the dollar amount is modest and does not signal a material change in outlook.

Actionable Insight

The proposed sale is small in absolute and relative terms, unlikely to move the stock. Monitor for any follow-on Form 4 filings to confirm execution, but no immediate trading action is warranted.

Key Facts

  • Insider: Jonathan M. Hopper, an officer of Vericel Corp
  • Proposed sale: 4,375 shares of common stock
  • Estimated value: $153,125 (based on $35.00/share approximate price)
  • Shares acquired via option grant dated February 6, 2019
  • Sale intended as cash transaction through Fidelity Brokerage Services LLC
  • Filing date: June 2, 2026
  • Recent insider activity: 5 sales totaling $588K in the past 30 days

Financial Impact

Proposed sale of $153,125 in shares, representing approximately 0.009% of market cap

dilution

Risk Factors

  • Insider selling pattern may continue, but current filing is too small to be material
  • No other material events or financial data in this filing to assess broader risk

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (14 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-004258
Document: 0001959173-26-004258-index.html0001959173-26-004258
Document: 0001959173-26-004258.txt0001959173-26-004258
8 reports for VCEL
Performance horizon
0% Hit rate 0 of 3 directional calls best @ T+20▼ −1.11%May 7, 2026
Filters
Rows
Reports for VCEL — sortable, filterable
Type Now
Jun 2, 2026
3d ago
144
NEUTRAL ★ 2/10
$34.45 $34.74▲ +0.84%▲ +1.54%$36.03 (+4.60%)
May 15, 2026
20d ago
Insider Cluster
NEUTRAL ★ 2/10
awaiting T+1
May 7, 2026
29d ago
8-K
BULLISH ★ 7/10
$35.13 $33.46▼ −4.75%▼ −5.58%$36.03 (+2.58%)
May 7, 2026
29d ago
Press Release
BULLISH ★ 8/10
$35.13 $33.46▼ −4.75%▼ −5.58%$36.03 (+2.58%)
Apr 23, 2026
6w ago
Press Release
NEUTRAL ★ 3/10
$34.40 $35.64▲ +3.60%▲ +2.82%$36.03 (+4.75%)
Mar 19, 2026
11w ago
DEFA14A
NEUTRAL ★ 3/10
$32.74 $31.41▼ −4.06%▼ −2.32%$36.03 (+10.06%)
Mar 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 4/10
$35.36 $34.39▼ −2.74%▼ −1.83%$36.03 (+1.91%)
Feb 26, 2026
14w ago
8-K
BULLISH ★ 8/10
$37.68 $35.68▼ −5.31%▼ −4.86%$36.03 (−4.37%)
Showing 8 of 8

US Market Status

Market Open — Closes in 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access